StockData
iBio, Inc. logo

iBio, Inc. (IBIO) stock

IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$0.85+0.10 (+13.37%)

Close on Nov 18, 2026Market cap $54.54MP/E –Yield –

iBio net income

Net income is the profit left for shareholders after every expense, interest and tax.

iBio's net income for the twelve months ending Sep 30, 2026 was -$34.88M. For fiscal 2026 it was -$33.04M. The highest annual figure on record is -$3.67M in fiscal 2014.

Annual net income

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$33.04M–
FY2025Jun 30, 2025-$18.38M–
FY2024Jun 30, 2024-$24.91M–
FY2023Jun 30, 2023-$65.01M–
FY2022Jun 30, 2022-$50.30M–
FY2021Jun 30, 2021-$23.21M–
FY2020Jun 30, 2020-$16.44M–
FY2019Jun 30, 2019-$17.59M–
FY2018Jun 30, 2018-$16.11M–
FY2017Jun 30, 2017-$14.53M–
FY2016Jun 30, 2016-$9.76M–
FY2015Jun 30, 2015-$6.63M–
FY2014Jun 30, 2014-$3.67M–
FY2013Jun 30, 2013-$6.20M–
FY2012Jun 30, 2012-$5.68M–
FY2011Jun 30, 2011-$12.14M–

Quarterly net income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026-$7.55M–
Q4 FY2026CQ2 2026Jun 30, 2026-$10.60M–
Q3 FY2026CQ1 2026Mar 31, 2026-$7.73M–
Q2 FY2026CQ4 2025Dec 31, 2025-$8.99M–
Q1 FY2026CQ3 2025Sep 30, 2025-$5.72M–
Q4 FY2025CQ2 2025Jun 30, 2025-$5.16M–
Q3 FY2025CQ1 2025Mar 31, 2025-$4.86M–
Q2 FY2025CQ4 2024Dec 31, 2024-$4.36M–
Q1 FY2025CQ3 2024Sep 30, 2024-$3.99M–
Q4 FY2024CQ2 2024Jun 30, 2024-$7.78M–
Q3 FY2024CQ1 2024Mar 31, 2024-$3.17M–
Q2 FY2024CQ4 2023Dec 31, 2023-$8.21M–
Q1 FY2024CQ3 2023Sep 30, 2023-$5.75M–
Q4 FY2023CQ2 2023Jun 30, 2023-$6.03M–
Q3 FY2023CQ1 2023Mar 31, 2023-$7.29M–
Q2 FY2023CQ4 2022Dec 31, 2022-$33.55M-29025.0%
Q1 FY2023CQ3 2022Sep 30, 2022-$18.13M–
Q4 FY2022CQ2 2022Jun 30, 2022-$17.05M–
Q3 FY2022CQ1 2022Mar 31, 2022-$12.39M–
Q4 FY2021CQ2 2021Jun 30, 2021$116.00K–
Q3 FY2021CQ1 2021Mar 31, 2021-$7.66M–
Q2 FY2021CQ4 2020Dec 31, 2020-$8.13M–
Q1 FY2021CQ3 2020Sep 30, 2020-$7.53M–
Q4 FY2020CQ2 2020Jun 30, 2020-$3.54M–
Q3 FY2020CQ1 2020Mar 31, 2020-$4.68M–
Q2 FY2020CQ4 2019Dec 31, 2019-$3.76M–
Q1 FY2020CQ3 2019Sep 30, 2019-$4.46M–
Q4 FY2019CQ2 2019Jun 30, 2019-$4.50M–
Q3 FY2019CQ1 2019Mar 31, 2019-$4.22M–
Q2 FY2019CQ4 2018Dec 31, 2018-$4.47M–
Q1 FY2019CQ3 2018Sep 30, 2018-$4.40M–
Q4 FY2018CQ2 2018Jun 30, 2018-$4.42M–
Q3 FY2018CQ1 2018Mar 31, 2018-$3.96M–
Q2 FY2018CQ4 2017Dec 31, 2017-$3.90M–
Q1 FY2018CQ3 2017Sep 30, 2017-$3.83M–
Q4 FY2017CQ2 2017Jun 30, 2017-$4.33M–
Q3 FY2017CQ1 2017Mar 31, 2017-$3.91M–
Q2 FY2017CQ4 2016Dec 31, 2016-$3.23M–
Q1 FY2017CQ3 2016Sep 30, 2016-$3.06M–

More iBio figures

See a number that looks wrong?